MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
$1,699,051
Accounts payable and
accrued expenses
$989,920
Common stock issued for
acquired technology...
$195,775
Unrealized loss on crypto
assets, at fair value
-$50,658
Prepaid expenses and
other current assets
-$38,239
Deferred revenue
$36,051
Impairment loss on crypto
assets, at cost
$29,911
Amortization of prepaid
stock-based professional...
$26,712
Unrealized loss on
short-term tokenized...
-$2,060
Net cash used in
operating activities
$3,058,438
Canceled cashflow
$13,850
Net decrease in cash
and cash...
-$858,014
Canceled cashflow
$3,058,438
Purchases of short-term
debt investments
-$57,910
Proceeds from the sale of
crypto assets
$45,188
Purchases of crypto assets
-$24,983
Stock-based compensation
-$8,093
Amortization expense
-$5,566
Staking income on crypto
assets
$191
something is missing
-$2,728,880
Net cash (used in)
provided by investing...
-$1,187,572
Canceled cashflow
$128,081
something is missing
-$1,315,653
Back
Back
Cash Flow
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)
source: myfinsight.com